| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |